OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Pulmonary Medicine is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	46
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	35
The persistent problem of persistent air-leaks: approach to management	34
The role of PET in the management of sarcoidosis	33
Home monitoring in asthma: towards digital twins	31
Bronchoscopic treatment of early-stage peripheral lung cancer	30
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	28
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	25
Digital outcome measures in pulmonary clinical trials	23
Improving care in lung cancer surgery: a review of quality measures and evolving standards	22
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	22
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	22
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	20
Implementation of digital home monitoring and management of respiratory disease	20
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	19
Group 2 pulmonary hypertension: from diagnosis to treatment	19
Considerations and clinical management of infections in sarcoidosis	19
Lung transplant referral considerations for individuals with cystic fibrosis	18
Editorial introductions	18
Asthma in pregnancy: a review of recent literature	17
The future of clinical trials in idiopathic pulmonary fibrosis	17
Casting light on the many facets of sarcoidosis	16
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	16
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	16
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	16

Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	15
Progress for all: addressing disparities in sarcoidosis	15
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	15
Cystic fibrosis liver disease in the post-modulator era	14
Tobacco treatment in the setting of lung cancer screening	14
Home monitoring of coronavirus disease 2019 patients in different phases of disease	14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	14
What causes cough in pulmonary fibrosis, and how should we treat it?	14
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	14
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	14
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	14
Digital inhalers for asthma management	14
Imaging in peripheral bronchoscopy	13
Acute rejection post lung transplant	13
Editorial: Are we ready for prime time?	12
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	12
Novel insights in fibrotic pulmonary sarcoidosis	12
Effectiveness and safety of coronavirus disease 2019 vaccines	12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	12
Exhaled breath analysis in interstitial lung disease	12
Patterns of progression in non-IPF fibrotic interstitial lung disease	12
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	12
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	12
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	11
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	11
Infection control in cystic fibrosis: evolving perspectives and challenges	11
Epigenetics and aging: relevance for sleep medicine	11
Telerehabilitation in pulmonary diseases	11
Multidisciplinary care in nonmalignant central airway obstruction	11
Altered pharmacology and toxicology during ageing: implications for lung disease	11
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	11
The association of preexisting severe asthma with COVID-19 outcomes	10
Editorial: ‘What is your occupation?’: historical snippets	10
Advancements in airway stents: a comprehensive update	10
The changing landscape of infections in the lung transplant recipient	10
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	10
Ergonomics in bronchoscopy	10
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	10
Adenotonsillectomy: the good, the bad and the unknown	10
Right ventricular assessment in pulmonary hypertension	10